ijms-logo

Journal Browser

Journal Browser

Molecular Mechanisms Underlying the Pathogenesis of Genetic Diseases

A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Genetics and Genomics".

Deadline for manuscript submissions: 20 March 2026 | Viewed by 895

Special Issue Editor


E-Mail Website
Guest Editor
Istituto di Biofisica (IBF), Consiglio Nazionale delle Ricerche (CNR), Via De Marini 6, 16149 Genova, Italy
Interests: protein processing; protein post-translational modifications; CFTR modulators; CFTR expression and functional assays; epithelial tissue models
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

It is my great pleasure to invite you to contribute to this Special Issue, entitled “Molecular Mechanisms Underlying the Pathogenesis of Genetic Diseases”, which I have the honor of Guest Editing.

Understanding the molecular mechanisms responsible for genetic diseases is crucial to elucidating their pathogenesis and developing targeted therapeutic strategies. This Special Issue invites the submission of high-quality contributions that investigate the molecular basis of genetic disorders, analyze genotype–phenotype correlations, and explore emerging approaches to diagnosis and therapy. Particular attention will be paid to omics-based approaches, the role of modifier genes, and the development of personalized treatments.

Additionally, we encourage submissions focused on the study of the mechanism of action of investigational molecules and drugs currently in clinical trials. Manuscripts addressing clinical trial outcomes, biomarkers for treatment response, and translational research efforts aimed at bridging the gap between basic science and clinical application are also welcome.

We invite original research articles, reviews, and perspective papers on topics including, but not limited to, the following:

  • Molecular mechanisms driving genetic diseases and their functional consequences;
  • Genotype–phenotype correlation and disease variability;
  • Multi-omics approaches (genomics, transcriptomics, proteomics, metabolomics) for studying genetic disorders;
  • The role of modifier genes in disease progression and therapeutic response;
  • Personalized medicine and innovative therapeutic strategies, including gene therapy and targeted pharmacological interventions;
  • Mechanisms of action of investigational molecules and drugs in clinical development;
  • Biomarkers and outcome measures in clinical trials for genetic diseases;
  • Translational research connecting molecular findings to clinical applications.

I look forward to receiving your valuable contributions to advance our understanding of genetic disease mechanisms and therapeutic strategies. Please feel free to contact me if you require any further information.

Dr. Debora Baroni
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • genetic diseases
  • genotype–phenotype correlations
  • multi-omics approaches
  • current and investigational therapeutical approaches
  • personalized medicine

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Review

22 pages, 2003 KB  
Review
Fabry Disease Beyond Storage: The Role of Inflammation in Disease Progression
by Giuseppa Biddeci, Gaetano Spinelli, Paolo Colomba, Giovanni Duro, Irene Giacalone and Francesco Di Blasi
Int. J. Mol. Sci. 2025, 26(15), 7054; https://doi.org/10.3390/ijms26157054 - 22 Jul 2025
Viewed by 632
Abstract
Fabry disease (FD) is a rare X-linked lysosomal storage disorder caused by mutations in the GLA gene, resulting in a deficient activity of the enzyme α-galactosidase A (α-Gal A). This deficiency leads to the progressive accumulation of globotriaosylceramide (Gb3) and its deacylated form, [...] Read more.
Fabry disease (FD) is a rare X-linked lysosomal storage disorder caused by mutations in the GLA gene, resulting in a deficient activity of the enzyme α-galactosidase A (α-Gal A). This deficiency leads to the progressive accumulation of globotriaosylceramide (Gb3) and its deacylated form, globotriaosylsphingosine (Lyso-Gb3), in various tissues, contributing to a broad spectrum of clinical manifestations. Recent evidence highlights the crucial role of inflammation in the pathophysiology of FD, influencing disease progression and clinical outcomes. This review provides a comprehensive overview of the relationship between inflammation and FD, with a particular focus on the impact of inflammatory processes on disease progression and complications. Full article
(This article belongs to the Special Issue Molecular Mechanisms Underlying the Pathogenesis of Genetic Diseases)
Show Figures

Figure 1

Back to TopTop